To overcome the complications of malaria (such as parasitemia) and inflammation in improving and assessing iron status, World Health Organization (WHO) recommends the use of serum concentration of soluble transferrin receptor (sTfR) in monitoring iron status in developing countries. Here, TFRC is linked to parasitic infectious disease.